Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies has submitted to BSE a compliance certificate from its Registrar and Share Transfer Agent (Accurate Securities & Registry Private Limited) for the quarter ended 30th June 2025. The certificate confirms that all physical securities received from depository participants for dematerialization during the quarter were processed within the SEBI-prescribed time limit. It also confirms that the cancelled/mutilated securities have been properly handled and the depository's name has been substituted as the registered owner in the company's records. The certificate was signed by Managing Director Bhumishth Patel on 14th July 2025.
This is a routine quarterly regulatory compliance filing with no material impact on the business, financials, or stock price. It simply confirms that the company's share transfer process is functioning as required by SEBI rules.